Antigen Loss after Targeted Immunotherapy in Hematological Malignancies
Ting Zhou(Memorial Sloan Kettering Cancer Center), Hao‐Wei Wang(Fu Jen Catholic University)
Cited by 22
Related Papers
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion
|Genes & Development|2010|744
CD4/CD8 T-Cell Selection Affects Chimeric Antigen Receptor (CAR) T-Cell Potency and Toxicity: Updated Results From a Phase I Anti-CD22 CAR T-Cell Trial
|Journal of Clinical Oncology|2020|422
STAT3 and STAT6 Signaling Pathways Synergize to Promote Cathepsin Secretion from Macrophages via IRE1α Activation
|Cell Reports|2016|204
Characterization of HLH-like manifestations as a CRS variant in patients receiving CD22 CAR T cells
|Blood|2021|194
Diagnosis of Hodgkin lymphoma in the modern era
|British Journal of Haematology|2018|184